Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Use of Internet Mediated Walking Program and Pedometer in COPD

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2013 by VA Boston Healthcare System.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
University of Michigan
Information provided by (Responsible Party):
Marilyn Moy, VA Boston Healthcare System
ClinicalTrials.gov Identifier:
NCT01772082
First received: January 16, 2013
Last updated: January 18, 2013
Last verified: January 2013
  Purpose
Persons with COPD are randomized to pedometer versus pedometer plus Internet mediated website to promote walking and physical activity. Primary outcome is 6-minute walk test distance. Intervention lasts 3 months.

Condition Intervention
COPD
Behavioral: Internet mediated walking program

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Randomized Study of Use of Internet Mediated Walking Program and Pedometer in COPD

Further study details as provided by VA Boston Healthcare System:

Primary Outcome Measures:
  • 6-minute walk test distance [ Time Frame: pre and 3 months post ] [ Designated as safety issue: No ]

Estimated Enrollment: 130
Study Start Date: January 2012
Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Pedometer alone
pedometer
Behavioral: Internet mediated walking program
Experimental: Pedometer plus website
pedometer and website
Behavioral: Internet mediated walking program

  Eligibility

Ages Eligible for Study:   40 Years to 90 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

COPD, ability to walk, has Internet access

Exclusion Criteria:

COPD exacerbation in previous 4 weeks

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01772082

Locations
United States, Massachusetts
VABoston Healthcare System
Boston, Massachusetts, United States, 02132
Sponsors and Collaborators
VA Boston Healthcare System
University of Michigan
  More Information

Responsible Party: Marilyn Moy, Assistant Professor of Medicine, VA Boston Healthcare System
ClinicalTrials.gov Identifier: NCT01772082     History of Changes
Other Study ID Numbers: ESCFull2328 
Study First Received: January 16, 2013
Last Updated: January 18, 2013
Health Authority: United States: Federal Government, VA Rehab R&D

ClinicalTrials.gov processed this record on December 08, 2016